ÂÜÀòÂÒÂ×

Andrew Taylor is an accomplished financial executive with extensive experience in the biomedical and medical technology sectors. Currently serving as the Chief Financial Officer at Orchestra BioMed since June 2023, Taylor leads financial strategies for a company focused on innovative biomedical technologies and strategic partnerships. Previously, Taylor held the position of President and Chief Financial Officer at Avertix Medical, contributing to its venture-backed medtech advancements. Notable prior roles include Chief Financial Officer at Motus GI Holdings, Inc. and fractional CFO consulting for Hale.life and Genome Profiling, LLC. Taylor's foundational experience includes practice leadership at AC Lordi Consulting and serving as CFO for Safe3w, Inc. Andrew Taylor holds an MBA in Accounting & Finance from D'Amore-McKim School of Business at Northeastern University and a BA in Political Science & Economics from McGill University.